Patients (P): Alla patients referred to Sahlgrenska University Hospital for the diagnostic work-up and management of a suspected pancreatic insulinoma.
Intervention (I): EUS-RFA
Control group (C): Patients with insulinoma treated with conventional surgery during the time frame 2018-2025 (historic controls).
Outcome (O):
* Technical feasibility
* Patient safety
* Clinical efficacy (follow-up with biochemistry and imaging at 3, 6, 12, and 24 months post-EUS-RFA).
